Literature DB >> 23523484

Descriptive analysis of the economic costs of periprosthetic joint infection of the knee for the public health system of Andalusia.

J Garrido-Gómez1, M A Arrabal-Polo, M S Girón-Prieto, J Cabello-Salas, J Torres-Barroso, J Parra-Ruiz.   

Abstract

This study offers a descriptive analysis of the economic costs of Periprosthetic joint infection (PJI) of the knee for the public health system of Andalusia (Spain) The data are based on consecutive patients with PJI treated in our Bone and Joint Infection Unit between January 2005 and January 2010. The total cost for all patients with knee PJI was 4,151,843 $ (3,202,841 €), i.e., a mean cost per patient of 52,555 $ (40,542 €). The mean cost per patient was 24,980 $ (19,270.80 €) for patients with early PJI and rose to 78,111 $ (60,257 €) for those with late PJI. The main cost was for the hospital stay and the specific in-hospital care received, followed by the cost of the surgical procedure.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  economic analysis; periprosthetic joint infection; total knee arthroplasty

Mesh:

Substances:

Year:  2013        PMID: 23523484     DOI: 10.1016/j.arth.2013.02.012

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

1.  What is the Long-term Economic Societal Effect of Periprosthetic Infections After THA? A Markov Analysis.

Authors:  Thomas J Parisi; Joseph F Konopka; Hany S Bedair
Journal:  Clin Orthop Relat Res       Date:  2017-04-07       Impact factor: 4.176

2.  [Anti-infective strategies in trauma surgery Part 1].

Authors:  C Willy; A Trampuz
Journal:  Unfallchirurg       Date:  2017-06       Impact factor: 1.000

3.  Cost of external fixation vs external fixation then nailing in bone infection.

Authors:  Khaled Mohamed Emara; Ramy Ahmed Diab; Khaled Abd El Ghafar
Journal:  World J Orthop       Date:  2015-01-18

4.  Screening of MRSA colonization in patients undergoing total joint arthroplasty.

Authors:  A M Valverde Villar; J Gutiérrez Del Álamo Oms; I Neira Borrajo; S de Miguel Fernández; P Flox Benítez; R Llopis Miró
Journal:  J Infect Prev       Date:  2021-06-23

5.  Revision for periprosthetic joint infection rate stratified by seasonality of operation in a national population of total and unicompartmental knee arthroplasty patients: a register-based analysis.

Authors:  Julius Tetens Hald; Anne Brun Hesselvig; Andreas Kryger Jensen; Anders Odgaard
Journal:  J Bone Jt Infect       Date:  2021-03-05

6.  Revision TKA with a condylar constrained prosthesis using metaphyseal and surface cementation: a minimum 6-year follow-up analysis.

Authors:  Pablo Sanz-Ruiz; Manuel Villanueva-Martínez; Jose Antonio Matas-Diez; Javier Vaquero-Martín
Journal:  BMC Musculoskelet Disord       Date:  2015-02-25       Impact factor: 2.362

7.  Temporal Change of Interleukin-6, C-Reactive Protein, and Skin Temperature after Total Knee Arthroplasty Using Triclosan-Coated Sutures.

Authors:  Shih-Jie Lin; Fu-Chun Chang; Tsan-Wen Huang; Kuo-Ti Peng; Hsin Nung Shih; Mel S Lee
Journal:  Biomed Res Int       Date:  2018-01-15       Impact factor: 3.411

8.  Economic Burden of Periprosthetic Joint Infection Following Primary Total Knee Replacement in a Developing Country.

Authors:  Faizan Iqbal; Bilal Shafiq; Syed Shahid Noor; Zulfiqar Ali; Nouman Memon; Naveed Memon
Journal:  Clin Orthop Surg       Date:  2020-11-18

9.  Cost-benefit analysis of antibiofilm microbiological techniques for peri-prosthetic joint infection diagnosis.

Authors:  Carlo L Romanò; Maria Teresa Trentinaglia; Elena De Vecchi; Nicola Logoluso; David A George; Ilaria Morelli; Lorenzo Drago
Journal:  BMC Infect Dis       Date:  2018-04-02       Impact factor: 3.090

10.  Underestimation of Staphylococcus aureus (MRSA and MSSA) carriage associated with standard culturing techniques: One third of carriers missed.

Authors:  S T J Tsang; M P McHugh; D Guerendiain; P J Gwynne; J Boyd; A H R W Simpson; T S Walsh; I F Laurenson; K E Templeton
Journal:  Bone Joint Res       Date:  2018-01       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.